Louis DesjardinsSummaryAffiliation: University of Montreal Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX studyLouis Desjardins
Service hématologie, CHU Laval, Ste Foy, Quebec, Canada
Arch Pathol Lab Med 128:519-26. 2004..Plasma anti-Xa and anti-IIa activities correlate with the dose of low-molecular-weight heparin, and D-dimer and thrombin-antithrombin complexes are markers of procoagulant activity...- Prospective evaluation of health-related quality of life in patients with deep venous thrombosisSusan R Kahn
Centre for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
Arch Intern Med 165:1173-8. 2005..To our knowledge, the burden of deep venous thrombosis from the patient's perspective has not been quantified. We evaluated health-related quality of life (QOL) after deep vein thrombosis and compared results with general population norms... - VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosisSusan R Kahn
Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
J Clin Epidemiol 59:1049-56. 2006..To assess the validity of VEINES-QOL/Sym, a patient-reported questionnaire to evaluate quality of life and symptoms in patients with deep venous thrombosis (DVT)... - Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosisSusan R Kahn
Centre for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
Ann Intern Med 149:698-707. 2008..The reason some patients with deep venous thrombosis (DVT) develop the postthrombotic syndrome is not well understood... - Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX studyRaza Alikhan
Academic Department of Surgery, Guy's, King's, St Thomas' School of Medicine, London, UK
Blood Coagul Fibrinolysis 14:341-6. 2003..22 (95% CI, 0.09-0.51); immobility, 0.53 (95% CI, 0.14-1.72); previous VTE, 0.49 (95% CI, 0.15-1.68); and cancer, 0.50 (95%o CI, 0.14-1.72). The beneficial effects of enoxaparin extend to a wide range of acutely ill medical patients... - Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX StudyRaza Alikhan
Academic Department of Surgery, Guy's, King's, and St Thomas' School of Medicine, London, England
Arch Intern Med 164:963-8. 2004..These findings allow recognition of individuals at increased risk of VTE and will contribute to the formulation of an evidence-based risk assessment model for thromboprophylaxis in hospitalized general medical patients... - Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in CanadaSusan R Kahn
Department of Medicine, McGill University, SMBD Jewish General Hospital, Canada
Thromb Res 119:145-55. 2007..Venous thromboembolism (VTE) prophylaxis in acutely ill medical patients has been shown to be safe and effective. Underutilization of this patient safety practice may result in avoidable mortality and morbidity...